Diagnostic and Interventional Cardiology

Observational research has suggested that light alcohol consumption may provide heart-related health benefits, but in a large study published in JAMA Network Open, alcohol intake at all levels was linked with higher risks of cardiovascular disease.

Large Study Challenges Theory that Light Alcohol Consumption Benefits Heart Health

April 4, 2022 – Observational research has suggested that light alcohol consumption may provide heart-related health ...

April 04, 2022

But scientists at the Medical College of Georgia and Georgia State University also say that the chronic high-salt diet most Americans consume can turn this system against us, resulting in hyperactivity of these neurons, continuing production of this hormone vasopressin, constriction of blood vessels and increasing our risk for common cardiometabolic diseases like high blood pressure and heart disease.

News | Heart Failure

New Clues About How A High-Salt Diet Contributes to Cardiometabolic Diseases Found Deep in the Brain

April 4, 2022 – Deep in the brain a group of large neurons produce a hormone which prompts our bodies to hold onto more ...

April 04, 2022

$Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the first patient has been enrolled in the quadruple-blinded sham-controlled AIM HIGHer IDE clinical study (Assessment of Implantable CCM in the Heart Failure Group with Higher Ejection Fraction) evaluating CCM therapy for patients who have left ventricular ejection fraction ranging between 40% and 60% inclusive. The study will be conducted across approximately 150 cente$

News | Heart Failure

Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer Study

April 4, 2022 – Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart ...

April 04, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

News | ACC

Esperion Announces Two NEXLETOL Data Presentations at ACC.22

April 4, 2022 – Esperion presented two new analyses from its clinical development program of bempedoic acid (NEXLETOL) ...

April 04, 2022

Significant VHD is commonly encountered in practice, more commonly with advancing age, among women, and identified more frequently in centers offering percutaneous mitral therapies.

News | ACC

egnite, Inc. Announces Data from the Largest Contemporary Analysis of Valvular Heart Disease Prevalence in the US

April 3, 2022 — egnite, Inc., an advanced technology digital health company focused on providing artificial intelligence ...

April 03, 2022

A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath, according to late-breaking research presented today at the American College of Cardiology (ACC) Scientific Session in Washington, D.C.

News | ACC

ACC22: Interim Findings Show Promise in Decreasing Shortness of Breath From Hypertrophic Cardiomyopathy

April 3, 2022 — A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath ...

April 03, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today presented detailed results from its phase 1 APOLLO trial

News | Heart Failure

Silence Therapeutics Announces Detailed Results from SLN360 Phase 1 Study in High Lipoprotein(a) Presented in Late Breaker at ACC22

April 3, 2022 — Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ...

April 03, 2022

Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance for its triage and notification of pneumothorax on X-ray exams.

News | Artificial Intelligence

Aidoc Expands AI Service to X-ray, Receiving FDA 510(k) Clearance for Pneumothorax

April 2, 2022 — Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance ...

April 02, 2022

Royal Philips, a global leader in health technology, today announced the launch of Ultrasound Workspace [OLK1] at the American College of Cardiology’s Annual Scientific Session & Expo (ACC 2022).

News | Cardiovascular Ultrasound

Philips Launches Ultrasound Workspace at ACC 2022

April 2, 2022 — Royal Philips, a global leader in health technology, today announced the launch of Ultrasound Workspace ...

April 02, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

New ACC/AHA/HFSA guideline redefines heart failure stages to focus on prevention, updates treatment options and emphasizes care coordination with a heart failure specialty team

News | Heart Failure

ACC, AHA, HFSA Issue Joint Heart Failure Guideline

April 1, 2022 — A new joint guideline published today from the American College of Cardiology, the American Heart ...

April 01, 2022

The poster titled “Short term prediction of Atrial Fibrillation from ambulatory ECG using deep learning” presents results of a clinical study demonstrating that Cardiologs’ AI algorithm can predict the short-term risk of atrial fibrillation (AFib) based on single-lead Ambulatory electrocardiograms (ECGs) that show normal sinus rhythm.

News | Atrial Fibrillation

Cardiologs Announces Poster Presentation at ACC 2022

April 1, 2022 — Cardiologs announced a poster presentation at the 2022 American College of Cardiology (ACC) meeting in ...

April 01, 2022

Philips Ambient Experience with FlexVision display for pediatric patients

News | ACC

Philips Adds to its Cardiology Suite of Solutions at ACC 2022

April 1, 2022 — Royal Philips, a global leader in health technology, announced new additions to its innovative ...

April 01, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

News | ACC

Aidoc Showcases Full Cardiovascular AI Care Coordination Suite at ACC.22

March 31, 2022 – Healthcare AI solutions provider Aidoc will be delivering a live demonstration of its comprehensive AI ...

March 31, 2022

News | ACC

ACC Scientific Session 2022 to Feature Smidt Heart Institute Experts

March 31, 2022 – Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and ...

March 31, 2022

News | ACC

CathWorks Presents New Data and Latest Innovations at ACC 2022

March 31, 2022 – CathWorks has announced that the results of its most recent outcomes study on the CathWorks FFRangio ...

March 31, 2022